Recently it has been described that blocking of the MCP-1 pathway results in reduced atherosclerosis and restenosis by inhibition of monocyte adhesion to the vascular wall and to reduced macrophage content in the atherosclerotic lesion [36]. Here, CCL2 is linked to atherosclerosis.